<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id><journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id><journal-id journal-id-type="pmc">nar</journal-id><journal-id journal-id-type="publisher-id">Nucleic Acids Research</journal-id><journal-title-group><journal-title>Nucleic Acids Research</journal-title></journal-title-group><issn pub-type="ppub">0305-1048</issn><issn pub-type="epub">1362-4962</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">17478518</article-id><article-id pub-id-type="pmc">PMC1904273</article-id><article-id pub-id-type="doi">10.1093/nar/gkm214</article-id><article-categories><subj-group subj-group-type="heading"><subject>Molecular Biology</subject></subj-group></article-categories><title-group><article-title>Transcription-coupled deposition of histone modifications during MHC class II gene activation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Rybtsova</surname><given-names>Natalia</given-names></name></contrib><contrib contrib-type="author"><name><surname>Leimgruber</surname><given-names>Elisa</given-names></name></contrib><contrib contrib-type="author"><name><surname>Seguin-Est&#x000e9;vez</surname><given-names>Queralt</given-names></name></contrib><contrib contrib-type="author"><name><surname>Dunand-Sauthier</surname><given-names>Isabelle</given-names></name></contrib><contrib contrib-type="author"><name><surname>Krawczyk</surname><given-names>Michal</given-names></name></contrib><contrib contrib-type="author"><name><surname>Reith</surname><given-names>Walter</given-names></name><xref ref-type="corresp" rid="COR1">*</xref></contrib></contrib-group><aff>Department of Pathology and Immunology, University of Geneva Medical School, 1 rue Michel-Servet, CH-1211, Geneva, Switzerland</aff><author-notes><corresp id="COR1">*To whom correspondence should be addressed. Tel: <phone>+41 22 379 56 66</phone>; Fax: <fax>+41 22 379 57 46</fax>; Email: <email>walter.reith@medecine.unige.ch</email></corresp><fn><p>The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors</p></fn></author-notes><pub-date pub-type="ppub"><month>5</month><year>2007</year></pub-date><pub-date pub-type="epub"><day>3</day><month>5</month><year>2007</year></pub-date><pub-date pub-type="pmc-release"><day>3</day><month>5</month><year>2007</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="epub"/>. --><volume>35</volume><issue>10</issue><fpage>3431</fpage><lpage>3441</lpage><history><date date-type="received"><day>3</day><month>11</month><year>2006</year></date><date date-type="rev-recd"><day>20</day><month>3</month><year>2007</year></date><date date-type="accepted"><day>27</day><month>3</month><year>2007</year></date></history><permissions><copyright-statement>&#x000a9; 2007 The Author(s)</copyright-statement><copyright-year>2007</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/2.0/uk/"><license-p><!--CREATIVE COMMONS-->This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/2.0/uk/">http://creativecommons.org/licenses/by-nc/2.0/uk/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Posttranslational histone modifications associated with actively expressed genes are generally believed to be introduced primarily by histone-modifying enzymes that are recruited by transcription factors or their associated co-activators. We have performed a comprehensive spatial and temporal analyses of the histone modifications that are deposited upon activation of the MHC class II gene <italic>HLA-DRA</italic> by the co-activator CIITA. We find that transcription-associated histone modifications are introduced during two sequential phases. The first phase precedes transcription initiation and is characterized exclusively by a rapid increase in histone H4 acetylation over a large upstream domain. All other modifications examined, including the acetylation and methylation of several residues in histone H3, are restricted to short regions situated at or within the 5&#x02032; end of the gene and are established during a second phase that is concomitant with ongoing transcription. This second phase is completely abrogated when elongation by RNA polymerase II is blocked. These results provide strong evidence that transcription elongation can play a decisive role in the deposition of histone modification patterns associated with inducible gene activation.</p></abstract></article-meta></front><body><sec><title>INTRODUCTION</title><p>The basic building block of eukaryotic chromatin is the nucleosome, which consists of 147&#x02009;bp of DNA wrapped around an octamer of the four core histone proteins H3, H4, H2A and H2B. The packaging of DNA into nucleosomes creates a restrictive environment that reduces the accessibility of DNA to factors that mediate chromatin-templated processes such as transcription. Dynamic structural rearrangements that render the chromatin permissive for transcription are therefore intimately associated with the regulation of gene expression. These structural rearrangements are believed to be facilitated by various posttranslational modifications of nucleosomal histones that affect chromatin structure either directly or by creating docking sites for the recruitment of effector proteins [for recent reviews see (<xref ref-type="bibr" rid="B1 B2 B3">1&#x02013;3</xref>)].</p><p>Among the most well-documented modifications associated with actively transcribed genes are the acetylation of various lysine residues in the N-terminal tails of H3 and H4 (H3Ac and H4Ac) (<xref ref-type="bibr" rid="B1">1</xref>), the di- and tri-methylation of lysine 4 in the N-terminal tail of H3 (H3K4Me2 and H3K4Me3) (<xref ref-type="bibr" rid="B2">2</xref>) and the methylation of arginine 17 in the N-terminal tail of H3 (H3R17Me2) (<xref ref-type="bibr" rid="B3">3</xref>). More recently, it has been shown that the methylation of lysine 9 in the N-terminal tail of H3 (H3K9Me3)&#x02014;a modification that was until then thought to be a hallmark of silent heterochromatin (<xref ref-type="bibr" rid="B2">2</xref>)&#x02014;is actually also found within the 5&#x02032; ends of several actively transcribed mammalian genes (<xref ref-type="bibr" rid="B4">4</xref>). It is now well established from studies in multiple model systems and species that there is a tight correlation between the presence of these histone modifications and active gene expression (<xref ref-type="bibr" rid="B1 B2 B3">1&#x02013;3</xref>). A widespread view is that histone-modifying activities are recruited by transcription factors and/or associated co-activators, and that they impact primarily on assembly of the general transcription machinery and transcription initiation (<xref ref-type="bibr" rid="B1 B2 B3">1&#x02013;3</xref>,<xref ref-type="bibr" rid="B5">5</xref>). However, there is also growing evidence suggesting that factors associated with elongating RNA polymerase can play a key role in establishing histone modifications associated with actively expressed genes (<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B6 B7 B8 B9 B10 B11">6&#x02013;11</xref>).</p><p>A full understanding of the mechanisms that mediate the deposition and functional consequences of specific histone modification patterns requires the analysis and integration of at least three related parameters: where in the gene the various different histone modifications are made, in what temporal order they are introduced and what steps in the transcription process they are implicated in (<xref ref-type="bibr" rid="B12 B13 B14 B15 B16">12&#x02013;16</xref>). Yet in the majority of higher eukaryotic systems these three parameters have not been integrated into a single comprehensive and dynamic description of the spatial distribution and temporal order of chromatin modification events that occur during the activation of transcription. We have performed such an analysis in one of the most well-defined human model systems, the activation of major histocompatibility complex class II (MHC-II) genes (<xref ref-type="bibr" rid="B17 B18 B19">17&#x02013;19</xref>).</p><p>Two modes of MHC-II expression, constitutive and inducible, are recognized (<xref ref-type="bibr" rid="B17 B18 B19">17&#x02013;19</xref>). Constitutive expression is restricted mainly to specialized cells of the immune system (thymic epithelial cells, dendritic cells, macrophages and B cells). Most other cell types do not express MHC-II genes unless they are exposed to interferon-&#x003b3; (IFN-&#x003b3;). The molecular machinery that regulates MHC-II expression has been exceptionally well defined thanks to the elucidation of the genetic defects that are responsible for the Bare Lymphocyte Syndrome, a rare hereditary immunodeficiency disease resulting from mutations in genes encoding transcription factors that are essential for MHC-II expression (<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B20 B21 B22 B23 B24">20&#x02013;24</xref>). One of these factors, the class II transactivator (CIITA) (<xref ref-type="bibr" rid="B20">20</xref>), is a transcriptional co-activator that is exquisitely specific for the activation of MHC-II genes (<xref ref-type="fig" rid="F1">Figure 1</xref>A). CIITA serves as the master regulator of MHC-II genes and is expressed in a cell-type-specific and IFN-&#x003b3;-inducible manner that dictates both the constitutive and inducible patterns of MHC-II expression (<xref ref-type="bibr" rid="B19">19</xref>). It is recruited to the regulatory regions of MHC-II genes by protein&#x02013;protein interactions with a multi-protein &#x02018;enhanceosome&#x02019; complex that assembles on a characteristic enhancer known as the MHC-II S-Y module (<xref ref-type="fig" rid="F1">Figure 1</xref>A) (<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B25 B26 B27 B28 B29">25&#x02013;29</xref>). A heterotrimeric DNA-binding factor called regulatory factor X (RFX) is a central component of the enhanceosome complex (<xref ref-type="fig" rid="F1">Figure 1</xref>A) (<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B21 B22 B23 B24">21&#x02013;24</xref>).
<fig id="F1" position="float"><label>Figure 1.</label><caption><p>Precise timing of IFN-&#x003b3;-induced <italic>HLA-DRA</italic> expression. (<bold>A</bold>) Molecular mechanism mediating IFN-&#x003b3;-induced <italic>HLA-DRA</italic> expression. IFN-&#x003b3; induces rapid expression of the gene coding for the transcriptional co-activator CIITA, which activates transcription of the <italic>HLA-DRA</italic> gene by associating with an enhanceosome complex that assembles at its proximal (S-Y) and distal (S&#x02032;-Y&#x02032;) regulatory modules. RFX is a key component of the enhanceosome complex. (<bold>B</bold>) Cell surface HLA-DR expression was measured by FACS in Me67.8 cells stimulated with IFN-&#x003b3; for 0, 24 and 48&#x02009;h. (<bold>C</bold>) The accumulation of CIITA and <italic>HLA-DRA</italic> mRNAs were quantified by real-time RT-PCR in IFN-&#x003b3;-stimulated Me67.8 cells over a 48-h time period. Shading highlights a 4-h lag period between the induction of CIITA and <italic>HLA-DRA</italic> mRNA accumulation. Results are expressed relative to the values measured after 48&#x02009;h. The mean and SD are shown for four experiments. (<bold>D</bold>) Occupation of the <italic>HLA-DRA</italic> S-Y and S&#x02032;-Y&#x02032; modules by CIITA and RFX was measured by quantitative chromatin immunoprecipitation (ChIP) at the indicated times following stimulation with IFN-&#x003b3;. Shaded bars highlight the occupation that is induced during the lag period preceding <italic>HLA-DRA</italic> gene activation. Results are expressed relative to the plateau values reached after 12&#x02009;h. The mean and SD are shown for two experiments.</p></caption><graphic xlink:href="gkm214f1"/></fig></p><p>The activation of MHC-II genes by CIITA is associated with an increase in many of the major histone modifications known to correlate with active transcription, including H3Ac, H4Ac, H3K4Me2, H3K4Me3 and H3R17Me2 (<xref ref-type="bibr" rid="B26 B27 B28 B29 B30 B31 B32">26&#x02013;32</xref>). Most studies examining these modifications have restricted themselves to the promoters of MHC-II genes (<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B30 B31 B32">30&#x02013;32</xref>), despite the fact that several reports have shown that they may affect distal regions as well (<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B29">29</xref>). Moreover, only limited information is available on when and in what order these modifications are introduced during the activation process (<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B32">32</xref>). We have therefore performed a comprehensive analysis of the spatial distribution, order and timing of the histone modifications that are introduced during IFN-&#x003b3;-induced activation of the prototypical MHC-II gene <italic>HLA-DRA</italic>. We demonstrate that there are two spatially and temporally distinct chromatin-modification phases. The first phase precedes the initiation of transcription and is characterized by a global increase in H4 acetylation throughout a large upstream domain. All other modifications are restricted to short regions situated within or near the 5&#x02032; end of the gene and are introduced in a second phase that coincides with, and is a consequence of, ongoing transcription. With the exception of H4Ac, most modifications observed at the <italic>HLA-DRA</italic> gene are thus established by transcription-coupled mechanisms.</p></sec><sec sec-type="materials|methods"><title>MATERIALS AND METHODS</title><sec><title>Cells</title><p>Me67.8 cells were grown in RPMI+Glutamax medium (Invitrogen) supplemented with 10% fetal calf serum and antibiotics, and were induced with 200&#x02009;U/ml of human IFN-&#x003b3; (Invitrogen) as described (<xref ref-type="bibr" rid="B33">33</xref>). Cell surface HLA-DR expression was analyzed by FACS as described (<xref ref-type="bibr" rid="B34">34</xref>). DRB (Sigma) was added to culture medium at a concentration of 100&#x02009;&#x003bc;M.</p></sec><sec><title>Chromatin immunoprecipitation (ChIP)</title><p>Chromatin preparation and ChIP experiments were performed as described using antibodies specific for RFX, CIITA and modified histones (<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B31">31</xref>). Results for modified histones were normalized using the TATA-binding protein (TBP) promoter as internal control and were compensated for fluctuations in nucleosome density by performing ChIP experiments in parallel with an antibody against unmodified H3. Histone antibodies were obtained from Abcam, Cambridge, UK (H3, Ab1791; H4K5Ac, Ab1758; H3K4Me3, Ab8580; H3K4Me2, Ab7766; H3K9Me3, Ab8898; H3K36me3, Ab9050) or Upstate, Lake Placid, NY (H4Ac, 06-866; H4K8Ac, 07-328; H4K12Ac, 07-595; H4K16Ac, 07-329; H3Ac, 06-599; H3K9Ac, 07-352; H3K14Ac, 07-353; H3K23Ac, 07-355; H3K27Ac, 07-360; H3R17Me3, 07-214). The RNA Pol II antibody was from Abcam (Ab817). Results were generated by real-time PCR using the primers listed in Supplementary Table 1. PCR was performed using the iCycler iQ Real-Time PCR Detection System (BioRad) and a SYBR-Green-based kit for quantitative PCR (iQ Supermix&#x02014;BioRad). Amplification specificity was controlled by gel electrophoresis and dissociation curve analysis. Results were quantified using a standard curve generated with serial dilutions of input DNA. PCR amplifications were performed in triplicate. Experiments were repeated between two and five times with different inductions.</p></sec><sec><title>RNA quantification</title><p>CIITA and DRA mRNAs were quantified by real-time RT-PCR and normalized with respect to TBP mRNA as described (<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B34">34</xref>). Chromatin-bound nascent and intergenic transcripts were isolated and quantified by real-time RT-PCR as described (<xref ref-type="bibr" rid="B26">26</xref>). Primers used for nascent and intergenic transcripts are listed in Supplementary Table 1. PCR measurements were made in triplicate. Experiments were repeated between two and four times with different inductions.</p></sec><sec><title>Immunoblotting</title><p>Cells were lysed for 1&#x02009;h on ice in 50&#x02009;mM Tris-HCl, pH 7.4, 150&#x02009;mM NaCl, 10&#x02009;mM EDTA, 1% NP40, 1&#x02009;mM DTT containing 1&#x000d7; complete&#x02122; protease inhibitors (Roche) and a phosphatase inhibitor cocktail (Sigma). Lysates were clarified by centrifugation and protein concentrations were determined. Proteins were dissolved in 2&#x000d7; sample buffer and equal amounts were fractionated by SDS-PAGE. Proteins were transferred to Immobilon-P membranes (Millipore), which were incubated with rabbit polyclonal CARM1 antibodies (Upstate 07-080, used at 1/1000 dilution), rabbit polyclonal CBP antibodies (SantaCruz sc-369, used at 1/500 dilution), rabbit polyclonal pCAF antibodies (Abcam ab12188, gift from W. Herr, used at 1/600 dilution), rabbit polyclonal Set1c antibodies (gift from W. Herr, used at 1/500 dilution), rabbit polyclonal WDR5 antibodies (gift from W. Herr, used at 1/500 dilution) and mouse monoclonal S2-phosphorylated-Pol II antibodies (Covance, MMS-129R). Detection was performed using peroxidase conjugated anti-mouse or anti-rabbit IgG antibodies (Promega) and chemiluminescence visualization (ECL, Amersham) according to the manufacturer's instructions. Blots were quantified using Quantity One software.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><sec><title>Precise timing of IFN-<bold>&#x003b3;</bold>-induced <italic>HLA-DRA</italic> gene transcription</title><p>Histone modifications introduced during IFN-&#x003b3;-induced activation of the <italic>HLA-DRA</italic> gene were studied in the melanoma cell line Me67.8, which was chosen because it exhibits a robust and reproducible induction of CIITA and MHC-II expression in response to INF-&#x003b3; (<xref ref-type="fig" rid="F1">Figure 1</xref>A) (<xref ref-type="bibr" rid="B33">33</xref>). Me67.8 cells respond to IFN-&#x003b3; in a synchronized manner, such that the entire population exhibits a homogeneous shift over time in the level of cell surface MHC-II expression (<xref ref-type="fig" rid="F1">Figure 1</xref>B).</p><p>Time course experiments were performed to document the activation of CIITA and <italic>HLA-DRA</italic> mRNA expression (<xref ref-type="fig" rid="F1">Figure 1</xref>C), as well as occupation of the <italic>HLA-DRA</italic> S-Y modules by CIITA and RFX (<xref ref-type="fig" rid="F1">Figure 1</xref>D). The time courses obtained for these parameters are highly reproducible from one experiment to another (see error bars in <xref ref-type="fig" rid="F1">Figure 1</xref>). CIITA mRNA accumulation starts 2&#x02009;h after induction, whereas the increase in <italic>HLA-DRA</italic> mRNA only becomes evident after 6&#x02009;h (<xref ref-type="fig" rid="F1">Figure 1</xref>C). During this 4-h lag period, occupation of the S-Y modules by CIITA and RFX increases to reach a plateau by 6&#x02009;h (<xref ref-type="fig" rid="F1">Figure 1</xref>D). These results define a precise 4-h time window during which key events implicated in CIITA-mediated transcriptional initiation of the <italic>HLA-DRA</italic> gene are most likely to occur.</p></sec><sec><title>Two distinct phases of histone acetylation</title><p>We performed chromatin immunoprecipitation (ChIP) experiments to examine changes in the levels of H3Ac and H4Ac that are induced over time within a 7-kb domain that spans 5&#x02009;kb of the upstream regulatory region and 2&#x02009;kb of the 5&#x02032; end of the <italic>HLA-DRA</italic> gene. Two spatially and temporally distinct histone acetylation phases were evident (<xref ref-type="fig" rid="F2">Figure 2</xref>). During the first phase, there was a strong increase in H4Ac over the entire region examined. This global increase in H4Ac was first evident after 3&#x02009;h of induction and reached nearly maximal levels by 6&#x02009;h. During the second phase, there was an increase in H3Ac that was restricted to a short 1-kb region situated within the 5&#x02032; end of the gene. This local increase in H3Ac occurred mainly between 6 and 12&#x02009;h after the start of induction.
<fig id="F2" position="float"><label>Figure 2.</label><caption><p>Spatial and temporal patterns of the induction of histone acetylation at the <italic>HLA-DRA</italic> gene. (<bold>A</bold>) The levels of H4 (top, H4Ac) and H3 (bottom, H3Ac) acetylation were measured by quantitative ChIP at different positions within the <italic>HLA-DRA</italic> gene in non-induced cells and cells treated with IFN-&#x003b3; for 12&#x02009;h. A schematic map of the <italic>HLA-DRA</italic> gene is shown below. (<bold>B</bold>) The levels of H4 (left) and H3 (right) acetylation were measured by quantitative ChIP at the indicated positions after induction with IFN-&#x003b3; for the indicated times. For H4Ac, similar time courses were also observed at the other positions examined in (A) (data not shown). Asterisk denotes not measured in all experiments. All results are expressed relative to the value observed at the promoter in non-induced cells. The mean and SD are shown for four (H4Ac) and five (H3Ac) experiments.</p></caption><graphic xlink:href="gkm214f2"/></fig></p><p>To define the precise lysine (K) residues that are implicated in the two phases, we performed ChIP experiments with antibodies directed against specific acetylated K residues of histones H4 and H3. During the first phase, H4 was acetylated mainly at K5 and K8 (<xref ref-type="fig" rid="F3">Figure 3</xref>A). No obvious increases in the acetylation of H4K12 and H4K16 were evident (<xref ref-type="fig" rid="F3">Figure 3</xref>A). As observed for H4Ac, the increases in H4K5Ac and H4K8Ac were early events that were essentially complete by 6&#x02009;h of induction (<xref ref-type="fig" rid="F3">Figure 3</xref>A) and concerned the entire 7-kb region (<xref ref-type="fig" rid="F3">Figure 3</xref>B). During the second phase, the strongest increase in acetylation was observed at K9 of H3 (<xref ref-type="fig" rid="F4">Figure 4</xref>A). There was a more modest increase for acetylation at H3K14, whereas no obvious changes were evident for acetylation at H3K23 and H3K27 (<xref ref-type="fig" rid="F4">Figure 4</xref>A). As for H3Ac, the increase in H3K9Ac was a late event occurring mainly after 6&#x02009;h of induction (<xref ref-type="fig" rid="F4">Figure 4</xref>A) and was restricted to the 5&#x02032; end of the gene (<xref ref-type="fig" rid="F4">Figure 4</xref>B). The acetylation specificity that we observed is consistent with previous reports showing that H4K8 and H3K9 are among the major residues that are acetylated at the <italic>HLA-DRA</italic> promoter in B cells and IFN-&#x003b3;-induced cells (<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B30">30</xref>).
<fig id="F3" position="float"><label>Figure 3.</label><caption><p>Specificity of H4 acetylation induced at the <italic>HLA-DRA</italic> gene. (<bold>A</bold>) The levels of acetylation at lysines K5, K8, K12 and K16 of H4 were measured by quantitative ChIP at the <italic>HLA-DRA</italic> promoter after induction with IFN-&#x003b3; for the indicated times. Similar results were obtained at the other positions in the region analyzed in (B) (data not shown). (<bold>B</bold>) Acetylation at H4K5 and H4K8 was measured by quantitative ChIP at the indicated positions in the <italic>HLA-DRA</italic> gene after 0 and 12&#x02009;h of induction. All results are expressed relative to the value observed at the promoter in non-induced cells. The mean and SD are shown for two experiments.</p></caption><graphic xlink:href="gkm214f3"/></fig>
<fig id="F4" position="float"><label>Figure 4.</label><caption><p>Specificity of H3 acetylation induced at the <italic>HLA-DRA</italic> gene. (<bold>A</bold>) The levels of acetylation at lysines K9, K14, K23 and K27 of H3 were measured by quantitative ChIP at position +300 of the <italic>HLA-DRA</italic> gene after induction with IFN-&#x003b3; for the indicated times. Similar results were obtained at the promoter and at +600 (data not shown). (<bold>B</bold>) H3 acetylation at K9 was measured by quantitative ChIP at the indicated positions in the <italic>HLA-DRA</italic> gene after 0 and 12&#x02009;h of induction. All results are expressed relative to the value observed at the promoter in non-induced cells. The mean and SD are shown for three experiments.</p></caption><graphic xlink:href="gkm214f4"/></fig></p><p>To situate the two phases of histone acetylation with respect to the initiation of transcription, we performed ChIP experiments to determine the timing of Pol II recruitment at the <italic>HLA-DRA</italic> promoter and the appearance of nascent chromatin-bound <italic>HLA-DRA</italic> transcripts (<xref ref-type="fig" rid="F5">Figure 5</xref>A). Pol II recruitment coincided with the increase in H4 acetylation and reached nearly maximal levels by 6&#x02009;h. In contrast, nascent transcripts appeared mainly after 6&#x02009;h, in parallel with the increase in H3 acetylation. The first phase of H4 acetylation is thus associated with Pol II recruitment but precedes the initiation of transcription. In contrast, the subsequent H3 acetylation phase appeared to coincide with active transcription. To confirm the latter, we performed a finer time course between 6 and 12&#x02009;h (<xref ref-type="fig" rid="F5">Figure 5</xref>B). The results indicate that the increase in H3 acetylation and the appearance of nascent transcripts are simultaneous events.
<fig id="F5" position="float"><label>Figure 5.</label><caption><p>Temporal relationship between the induction of histone acetylation, the recruitment of Pol II and the initiation of transcription. (<bold>A</bold>) H4 acetylation, H3 acetylation, recruitment of Pol II and the appearance of nascent chromatin-bound transcripts were quantified after the indicated times in IFN-&#x003b3;-induced cells. For H4Ac, the results represent the mean and SD for measurements made in three to four experiments at four positions (&#x02212;1.3, &#x02212;0.1, +0.3 and +0.6&#x02009;kb) in the <italic>HLA-DRA</italic> gene. For H3Ac, the results represent the mean and SD for measurements made in three to five experiments at three positions (&#x02212;0.1, +0.3 and +0.6&#x02009;kb) in the <italic>HLA-DRA</italic> gene. For nascent transcripts, the results represent the mean and SD for measurements made in two experiments at three positions (+0.3, +0.6 and +1.7&#x02009;kb) within the <italic>HLA-DRA</italic> gene. For Pol II, results represent the mean and SD for measurements made at the promoter (&#x02212;0.04&#x02009;kb) in four experiments. Asterisk denotes not measured in all experiments. (<bold>B</bold>) Nascent chromatin-bound transcripts (open bars) and H3 acetylation (gray bars) were quantified in IFN-&#x003b3;-induced cells after the indicated times. Results represent the mean and SD from two experiments.</p></caption><graphic xlink:href="gkm214f5"/></fig></p></sec><sec><title>H4 acetylation is associated with intergenic transcription</title><p>Constitutive expression of the <italic>HLA-DRA</italic> gene in B cells is associated with intergenic transcription of its upstream regulatory region (<xref ref-type="bibr" rid="B26">26</xref>). We therefore determined whether these intergenic transcripts are also observed in IFN-&#x003b3;-induced cells (<xref ref-type="fig" rid="F6">Figure 6</xref>). Intergenic transcripts were induced during the early phase of H4 acetylation, prior to transcription of the <italic>HLA-DRA</italic> gene itself. The abundance of these intergenic transcripts is highest just upstream of the promoter and in regions that flank the distal S&#x02032;-Y&#x02032; module (<xref ref-type="fig" rid="F6">Figure 6</xref>). This IFN-&#x003b3;-induced pattern of intergenic transcription is similar to the one observed previously in B cells (<xref ref-type="bibr" rid="B26">26</xref>).
<fig id="F6" position="float"><label>Figure 6.</label><caption><p>Intergenic transcription induced by IFN-&#x003b3; in the upstream region of the HLA-DRA gene. Intergenic transcripts were quantified by real-time RT-PCR at the indicated times and positions in the upstream region of the <italic>HLA-DRA</italic> gene. In the time course experiment (top), the results represent the mean and SD of measurements made in three experiments at six positions (&#x02212;4.9, &#x02212;3.5, &#x02212;2.3, &#x02212;1.8, &#x02212;1.3 and &#x02212;0.1&#x02009;kb) in the upstream region. The spatial distribution (bottom) shows the mean and SD derived from three experiments in cells induced for 0 and 12&#x02009;h. Asterisk denotes not measured in all experiments.</p></caption><graphic xlink:href="gkm214f6"/></fig></p></sec><sec><title>H3 acetylation coincides with increased H3 methylation</title><p>To examine where and when changes in H3 methylation occur during IFN-&#x003b3;-induced expression of the <italic>HLA-DRA</italic> gene, we performed ChIP experiments with antibodies directed against H3K4Me3, H3K4Me2, H3R17Me2 and H3K9Me3 (<xref ref-type="fig" rid="F7">Figure 7</xref>). Increases restricted to short regions situated near the 5&#x02032; end of the <italic>HLA-DRA</italic> gene were observed for all four modifications. The increases in H3K4Me3, H3K4Me2 and H3K9Me3 peaked at a position situated after the transcription initiation site. The strongest increase in H3R17Me2 was situated at the transcription initiation site. These methylation events occurred mainly after 6&#x02009;h, although the increase in H3K4Me2 appeared to precede the others somewhat. Taken together, these results show that introduction of the H3 methylation marks overlaps temporally and spatially with increased H3 acetylation.
<fig id="F7" position="float"><label>Figure 7.</label><caption><p>Temporal and spatial pattern of IFN-&#x003b3;-induced H3 methylation. The induction of (<bold>A</bold>) H3K4Me2, (<bold>B</bold>) H3K4Me3, (<bold>C</bold>) H3R17Me2 and (<bold>D</bold>) H3K9Me3 modifications were assessed at the indicated times and positions in the <italic>HLA-DRA</italic> gene. In the left panels, results are presented for cells induced with IFN-&#x003b3; for 0 and 12&#x02009;h. In the right panels, time courses are shown for positions at which the modifications attain a peak. The mean and SD are shown for two experiments. Asterisk denotes not measured in all experiments.</p></caption><graphic xlink:href="gkm214f7"/></fig></p></sec><sec><title>All H3 modifications are transcription dependent</title><p>With respect to both their timing and position, the increases in H3 acetylation and methylation coincide with active transcription of the <italic>HLA-DRA</italic> gene, raising the possibility that they might actually be a consequence of transcription. To address this possibility, we induced cells with IFN-&#x003b3; for 6&#x02009;h to permit the induction of CIITA expression and completion of the early H4 acetylation phase, and then continued the induction in the presence of the drug 5,6-dichloro-1-&#x003b2;-<sc>d</sc>-ribofuranosylbenzimidazole (DRB) (<xref ref-type="fig" rid="F8">Figure 8</xref>A), which blocks transcription elongation by inhibiting phosphorylation of the C-terminal domain (CTD) of Pol II (<xref ref-type="fig" rid="F8">Figure 8</xref>B) (<xref ref-type="bibr" rid="B35">35</xref>,<xref ref-type="bibr" rid="B36">36</xref>). This protocol completely blocked the induction of <italic>HLA-DRA</italic> mRNA accumulation (<xref ref-type="fig" rid="F8">Figure 8</xref>C) and reduced Pol II density within the body of the gene (Supplementary Figure 1). As expected, DRB did not significantly affect HLA-DRA promoter occupation by RFX and CIITA, the acetylation of H4 or recruitment of Pol II to the promoter (<xref ref-type="fig" rid="F8">Figure 8</xref>B and C). Events that precede the initiation of <italic>HLA-DRA</italic> transcription had thus been completed and were not reversed by the addition of DRB. In contrast, the increases in H3Ac, H3K4Me3, H3K4Me2, H3R17Me2 and H3K9Me3, which occur mainly after 6&#x02009;h, were all completely eliminated by DRB. The introduction of these five modifications thus behaves in a manner similar to that of the H3K36Me3 modification (<xref ref-type="fig" rid="F8">Figure 8</xref>C), which is known to be strictly dependent on active Pol II elongation (<xref ref-type="bibr" rid="B2">2</xref>).
<fig id="F8" position="float"><label>Figure 8.</label><caption><p>Most IFN-&#x003b3;-induced histone modifications deposited at the HLA-DRA gene are a consequence of active transcription. (<bold>A</bold>) The diagram depicts the protocol used to document the effect of DRB on IFN-&#x003b3;-induced HLA-DRA gene activation. (<bold>B</bold>) The effect of DRB on the phosphorylation of Pol II was assessed by western blotting (left), whereas its effect on HLA-DRA promoter occupation by RFX (right) and CIITA (middle) was measured by ChIP. (<bold>C</bold>) HLA-DRA mRNA accumulation, the recruitment of Pol II at the promoter, and the levels of the indicated modifications were measured after 0, 6 and 12&#x02009;h of induction with IFN-&#x003b3;, and after 12&#x02009;h of induction in the presence of DRB for the last 6&#x02009;h. Results are shown for measurements made at the promoter (Pol II and R17Me2), at +300 (H4Ac, H3Ac, H3K4Me3, H3K4Me2 and H3K9Me3) and in exon 5 (H3K36Me3). Similar results were obtained at other positions in the modified regions (data not shown). The mean and SD are shown for two experiments. (<bold>D</bold>) Protein levels of the indicated histone modifying factors were measured by western blotting in cells treated as in panel C.</p></caption><graphic xlink:href="gkm214f8"/></fig></p><p>To ascertain that the DRB sensitivity of the H3Ac, H3K4Me3, H3K4Me2, H3R17Me2 and H3K9Me3 modifications is not a non-specific consequence of a general block in the transcription of genes encoding histone-modifying factors, we examined the levels of several key proteins by western blotting experiments. These included the histone acetyltransferase (HAT) factors [cyclic AMP responsive-element binding-protein (CBP) and p300/CBP-associated factor (pCAF)], the histone methyltransferase (HMT) factors (Set1 and WDR5), and the H3R17-specific HMT CARM1 (<xref ref-type="fig" rid="F8">Figure 8</xref>D). We also examined the HAT GCN5 (data not shown). No drop in the abundance of any of these proteins was induced by the 6-h DRB treatment.</p><p>Taken together, these results are consistent with the model that the H3Ac, H3K4Me3, H3K4Me2, H3R17Me2 and H3K9Me3 modifications are introduced in a transcription-coupled manner during IFN-&#x003b3;-induced activation of the HLA-DRA gene.</p></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>Our results demonstrate that histone modifications associated with IFN-&#x003b3;-induced <italic>HLA-DRA</italic> gene activation are introduced during two sequential phases that differ with respect to their timing, the regions of the gene that are concerned, the precise modifications that are made and their dependence on ongoing transcription. The first phase precedes the initiation of transcription and is characterized by a rapid increase in H4K5 and H4K8 acetylation over a large upstream domain. The second phase is concomitant with active transcription and is characterized by increases in H3K9Ac, H3K4Me2, H3K4Me3, H3K9Me3 and H3R17Me2 in short regions situated at or within the 5&#x02032; end of the gene. This second phase is completely blocked by the transcription elongation inhibitor DRB, indicating that it is a consequence of active elongation by Pol II.</p><p>The timing, localization and transcription-dependence of the increases in H3Ac, H3K4Me2, H3K4Me3, H3K9Me3 and H3R17Me2 suggest that these marks are introduced by HATs and HMTs that are recruited by actively transcribing Pol II, associated elongation factors and/or prior histone modifications that were introduced in a transcription-dependent manner. Moreover, they imply that most histone modifications introduced during <italic>HLA-DRA</italic> gene activation do not play a role in facilitating assembly of the general transcription machinery and transcription initiation, but are instead likely to be implicated in subsequent processes such as promoter clearance, transcription elongation and/or the establishment of transcriptional memory. These conclusions are consistent with previous reports suggesting that phosphorylation of the CTD of Pol II by the CDK7 subunit of the general transcription factor TFIIH and the CDK9 subunit of the transcription elongation factor pTEFb are key events in CIITA-induced MHC-II gene expression (<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B37">37</xref>). In contrast, our results challenge current models proposing that CIITA serves as a scaffolding protein that recruits and coordinates all key chromatin-modifying activities at MHC-II promoters, and that the modifications introduced by these activities are primarily required for transcription initiation at MHC-II genes (<xref ref-type="bibr" rid="B5">5</xref>).</p><p>Among the histone modifications we have examined, only the rapid and long-range increase in H4 acetylation coincides temporally with the recruitment of CIITA and occurs prior to and independently of active transcription of the <italic>HLA-DRA</italic> gene. This suggests that only the early H4 acetylation phase is likely to be mediated by HATs that are recruited directly by CIITA. HATs that are believed to be able to cooperate with CIITA include CBP, pCAF, GCN5 and steroid receptor co-activator (SRC)-1. These HATs have been reported to be recruited to MHC-II promoters in B cells and IFN-&#x003b3;-induced cells, can interact with CIITA <italic>in vitro</italic> and upon over expression in transfected cells, and can activate MHC-II reporter genes in synergy with CIITA in transient transfection experiments (<xref ref-type="bibr" rid="B38 B39 B40 B41 B42">38&#x02013;42</xref>). However, we have so far been unable to document a robust and reproducible recruitment of any of these HATs in a pattern that coincides temporally and spatially with the binding of CIITA and the early increase in H4 acetylation. One explanation that could account for this discrepancy is that these HATs associate only transiently with the HLA-DRA upstream region. Alternatively, other HATs could be implicated. Since CIITA has been reported to have intrinsic HAT activity (<xref ref-type="bibr" rid="B43">43</xref>), one possibility is that CIITA itself might be responsible for the increase in H4 acetylation. A second intriguing possibility is suggested by the finding that intergenic transcription is induced in the <italic>HLA-DRA</italic> upstream region according to a pattern that is similar to that observed for H4 acetylation with respect to both timing and spatial distribution. Intergenic transcription has been attributed a regulatory function in the establishment of open chromatin domains in several systems (<xref ref-type="bibr" rid="B44 B45 B46 B47 B48 B49">44&#x02013;49</xref>). It has notably been suggested to contribute to the function of locus control regions (LCRs) (<xref ref-type="bibr" rid="B44">44</xref>,<xref ref-type="bibr" rid="B45">45</xref>,<xref ref-type="bibr" rid="B49">49</xref>). Among other models, it has been postulated that the regulatory role of intergenic transcription could be due to chromatin remodeling activities&#x02014;such as HATs&#x02014;that track along the chromatin with Pol II (<xref ref-type="bibr" rid="B50 B51 B52 B53 B54 B55">50&#x02013;55</xref>). Since the HLA-DRA upstream regions exhibit properties typical of LCRs (<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B56 B57 B58">56&#x02013;58</xref>), it is tempting to speculate that such a tracking mechanism is operating during the early phase of H4 acetylation observed during <italic>HLA-DRA</italic> gene activation. We can however not exclude the possibility that the intergenic transcription is a consequence rather than a cause of increased H4 acetylation.</p><p>Our results highlight a dominant role of transcription elongation in the recruitment of histone-modifying activities during the induction of MHC-II gene expression. This is at odds with widespread models of gene regulation postulating that HATs and HMTs are primarily recruited by DNA-bound transcription factors and their associated co-activators (<xref ref-type="bibr" rid="B1 B2 B3">1&#x02013;3</xref>,<xref ref-type="bibr" rid="B5">5</xref>). However, there is growing evidence that a decisive role of transcription elongation in the establishment of histone modifications is not just a peculiarity of the MHC-II system.</p><p>There is strong evidence for a link between deposition of the H3K4Me3 mark and transcription elongation in <italic>Saccharomyces cerevisiae</italic>. Set1&#x02014;the HMT responsible for methylating H3K4 in yeast&#x02014;is recruited to the elongating CTD-phosphorylated form of Pol II by its interaction with the elongation factor Paf1 (<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B6 B7 B8">6&#x02013;8</xref>). This mode of recruitment is consistent with the results of genome-wide mapping studies, which have shown that the density of H3K4 methylation generally peaks within the 5&#x02032; transcribed portion of active yeast genes (<xref ref-type="bibr" rid="B59">59</xref>,<xref ref-type="bibr" rid="B60">60</xref>). The link between H3K4 methylation and transcription elongation is less well established in higher eukaryotes. Set1 homolog in higher eukaryotes&#x02014;of which there are several&#x02014;have in fact been reported to be recruited by interactions with specific transcription factors (<xref ref-type="bibr" rid="B61 B62 B63 B64 B65">61&#x02013;65</xref>). However, large-scale mapping studies in <italic>Drosophila melanogaster</italic> and humans, as well as a more limited study in the chicken, have demonstrated that H3K4 methylation is, like in yeast, frequently concentrated within the 5&#x02032; transcribed regions of active genes (<xref ref-type="bibr" rid="B66 B67 B68 B69 B70">66&#x02013;70</xref>). Moreover, a protein fraction enriched in H3K4-specific HMT activity was recently reported to introduce the H3K4Me3 modification in a transcription-coupled manner in a reconstituted human <italic>in vitro</italic> transcription system (<xref ref-type="bibr" rid="B71">71</xref>). These findings suggest that a transcription-dependent mode of recruitment of H3K4-specific HMTs is conserved in higher eukaryotes.</p><p>There are also indications that H3 acetylation may be coupled to transcription elongation at numerous genes in diverse species. Large-scale mapping studies performed in <italic>S. cerevisiae</italic>, <italic>Schizosaccharomyces pombe</italic>, <italic>D. melanogaster</italic> and humans have established that the density of H3 acetylation tends to peak, as observed here at the HLA-DRA gene, within the 5&#x02032; transcribed region of expressed genes (<xref ref-type="bibr" rid="B59">59</xref>,<xref ref-type="bibr" rid="B60">60</xref>,<xref ref-type="bibr" rid="B67">67</xref>,<xref ref-type="bibr" rid="B68">68</xref>,<xref ref-type="bibr" rid="B70">70</xref>,<xref ref-type="bibr" rid="B72">72</xref>,<xref ref-type="bibr" rid="B73">73</xref>). This intragenic localization would be consistent with a widespread role of active transcription in increasing H3 acetylation. Transcription-dependent H3 acetylation could be mediated by HATs, such as the elongator complex, that travel along chromatin in association with elongating Pol II (<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B51 B52 B53 B54">51&#x02013;54</xref>). Alternatively, several findings suggest that H3 acetylation could be coupled to H3K4 methylation. Large-scale mapping studies have shown that the patterns of H3Ac and H3K4Me3 often coincide (<xref ref-type="bibr" rid="B59">59</xref>,<xref ref-type="bibr" rid="B60">60</xref>,<xref ref-type="bibr" rid="B67">67</xref>,<xref ref-type="bibr" rid="B68">68</xref>,<xref ref-type="bibr" rid="B70">70</xref>,<xref ref-type="bibr" rid="B72">72</xref>,<xref ref-type="bibr" rid="B73">73</xref>). Moreover, methylation at K4 makes H3&#x02009;a preferential target for dynamic changes in acetylation (<xref ref-type="bibr" rid="B74">74</xref>). Finally, histone-modifying complexes containing both HAT and H3K4-specific HMT subunits have been identified in yeast, <italic>D. melanogaster</italic> and humans (<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B65">65</xref>,<xref ref-type="bibr" rid="B75">75</xref>).</p><p>The recruitment of CARM1, the HMT responsible for making the H3R17Me2 modification, is believed to be mediated by interactions with specific transcription factors or co-activators (<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B32">32</xref>,<xref ref-type="bibr" rid="B76">76</xref>). However, in two systems CARM1 recruitment has been shown to be dependent on the prior acetylation of H3 (<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B15">15</xref>). Tethering of CARM1 to chromatin modifications established during active transcription, such as H3 acetylation, might thus constitute an alternative pathway for CARM1 recruitment.</p><p>Finally, our results extend the recent discovery that the H3K9Me3 mark is introduced into the 5&#x02032; transcribed region of mouse and human genes by a transcription-elongation-dependent process (<xref ref-type="bibr" rid="B4">4</xref>). As observed here at the <italic>HLA-DRA</italic> gene, this previous report also demonstrated co-localization between the H3K9Me3 and H3K4Me3 marks, suggesting that their introduction might be coupled (<xref ref-type="bibr" rid="B4">4</xref>).</p><p>Taken together, the findings outlined above suggest that transcription elongation may play a critical role in establishing histone-modification patterns associated with many actively expressed genes in species ranging from yeast to humans. The results reported here for activation of the <italic>HLA-DRA</italic> gene are thus likely to be of widespread relevance to numerous gene regulatory systems in diverse species.</p></sec><sec sec-type="supplementary-material"><title>SUPPLEMENTARY DATA</title><p>Supplementary Data are available at NAR Online.</p>
<supplementary-material id="PMC_1" content-type="local-data">
<caption>
<title>[Supplementary Material]</title>
</caption>
<media mimetype="text" mime-subtype="html" xlink:href="nar_gkm214_index.html"/>
<media xlink:role="associated-file" mimetype="application"
mime-subtype="vnd.ms-powerpoint"
xlink:href="nar_gkm214_nar-02524-w-2006-File003.ppt"/>
<media xlink:role="associated-file" mimetype="application" mime-subtype="msword"
xlink:href="nar_gkm214_nar-02524-w-2006-File004.doc"/>
</supplementary-material>
</sec></body><back><ack><title>ACKNOWLEDGEMENTS</title><p>We are grateful to Michel Strubin, Iannis Talianidis, and current and past members of the laboratory for valuable discussions and critical reading of the manuscript. This work was supported by the Swiss National Science Foundation. Funding to pay the Open Access publication charges for this article was provided by the Swiss National Science Foundation.</p><p><italic>Conflict of interest statement</italic>. None declared.</p></ack><ref-list><title>REFERENCES</title><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurdistani</surname><given-names>SK</given-names></name><name><surname>Grunstein</surname><given-names>M</given-names></name></person-group><article-title>Histone acetylation and deacetylation in yeast</article-title><source>Nat. Rev. Mol. Cell Biol</source><year>2003</year><volume>4</volume><fpage>276</fpage><lpage>284</lpage><pub-id pub-id-type="pmid">12671650</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name></person-group><article-title>The diverse functions of histone lysine methylation</article-title><source>Nat. Rev. Mol. Cell Biol</source><year>2005</year><volume>6</volume><fpage>838</fpage><lpage>849</lpage><pub-id pub-id-type="pmid">16261189</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wysocka</surname><given-names>J</given-names></name><name><surname>Allis</surname><given-names>CD</given-names></name><name><surname>Coonrod</surname><given-names>S</given-names></name></person-group><article-title>Histone arginine methylation and its dynamic regulation</article-title><source>Front Biosci</source><year>2006</year><volume>11</volume><fpage>344</fpage><lpage>355</lpage><pub-id pub-id-type="pmid">16146736</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vakoc</surname><given-names>CR</given-names></name><name><surname>Mandat</surname><given-names>SA</given-names></name><name><surname>Olenchock</surname><given-names>BA</given-names></name><name><surname>Blobel</surname><given-names>GA</given-names></name></person-group><article-title>Histone H3 lysine 9 methylation and HP1gamma are associated with transcription elongation through mammalian chromatin</article-title><source>Mol. Cell</source><year>2005</year><volume>19</volume><fpage>381</fpage><lpage>391</lpage><pub-id pub-id-type="pmid">16061184</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname><given-names>KL</given-names></name><name><surname>Ting</surname><given-names>JP</given-names></name></person-group><article-title>Epigenetic regulation of MHC-II and CIITA genes</article-title><source>Trends Immunol</source><year>2006</year><volume>27</volume><fpage>405</fpage><lpage>412</lpage><pub-id pub-id-type="pmid">16870508</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krogan</surname><given-names>NJ</given-names></name><name><surname>Dover</surname><given-names>J</given-names></name><name><surname>Wood</surname><given-names>A</given-names></name><name><surname>Schneider</surname><given-names>J</given-names></name><name><surname>Heidt</surname><given-names>J</given-names></name><name><surname>Boateng</surname><given-names>MA</given-names></name><name><surname>Dean</surname><given-names>K</given-names></name><name><surname>Ryan</surname><given-names>OW</given-names></name><name><surname>Golshani</surname><given-names>A</given-names></name><etal/></person-group><article-title>The Paf1 complex is required for histone H3 methylation by COMPASS and Dot1p: linking transcriptional elongation to histone methylation</article-title><source>Mol. Cell</source><year>2003</year><volume>11</volume><fpage>721</fpage><lpage>729</lpage><pub-id pub-id-type="pmid">12667454</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>HH</given-names></name><name><surname>Robert</surname><given-names>F</given-names></name><name><surname>Young</surname><given-names>RA</given-names></name><name><surname>Struhl</surname><given-names>K</given-names></name></person-group><article-title>Targeted recruitment of Set1 histone methylase by elongating Pol II provides a localized mark and memory of recent transcriptional activity</article-title><source>Mol. Cell</source><year>2003</year><volume>11</volume><fpage>709</fpage><lpage>719</lpage><pub-id pub-id-type="pmid">12667453</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eissenberg</surname><given-names>JC</given-names></name><name><surname>Shilatifard</surname><given-names>A</given-names></name></person-group><article-title>Leaving a mark: the many footprints of the elongating RNA polymerase II</article-title><source>Curr. Opin. Genet. Dev</source><year>2006</year><volume>16</volume><fpage>184</fpage><lpage>190</lpage><pub-id pub-id-type="pmid">16503129</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Close</surname><given-names>P</given-names></name><name><surname>Hawkes</surname><given-names>N</given-names></name><name><surname>Cornez</surname><given-names>I</given-names></name><name><surname>Creppe</surname><given-names>C</given-names></name><name><surname>Lambert</surname><given-names>CA</given-names></name><name><surname>Rogister</surname><given-names>B</given-names></name><name><surname>Siebenlist</surname><given-names>U</given-names></name><name><surname>Merville</surname><given-names>MP</given-names></name><name><surname>Slaugenhaupt</surname><given-names>SA</given-names></name><etal/></person-group><article-title>Transcription impairment and cell migration defects in elongator-depleted cells: implication for familial dysautonomia</article-title><source>Mol. Cell</source><year>2006</year><volume>22</volume><fpage>521</fpage><lpage>531</lpage><pub-id pub-id-type="pmid">16713582</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saunders</surname><given-names>A</given-names></name><name><surname>Core</surname><given-names>LJ</given-names></name><name><surname>Lis</surname><given-names>JT</given-names></name></person-group><article-title>Breaking barriers to transcription elongation</article-title><source>Nat. Rev. Mol. Cell Biol</source><year>2006</year><volume>7</volume><fpage>557</fpage><lpage>567</lpage><pub-id pub-id-type="pmid">16936696</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>ST</given-names></name><name><surname>Petruk</surname><given-names>S</given-names></name><name><surname>Sedkov</surname><given-names>Y</given-names></name><name><surname>Cho</surname><given-names>E</given-names></name><name><surname>Tillib</surname><given-names>S</given-names></name><name><surname>Canaani</surname><given-names>E</given-names></name><name><surname>Mazo</surname><given-names>A</given-names></name></person-group><article-title>Modulation of heat shock gene expression by the TAC1 chromatin-modifying complex</article-title><source>Nat. Cell Biol</source><year>2004</year><volume>6</volume><fpage>162</fpage><lpage>167</lpage><pub-id pub-id-type="pmid">14730313</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metivier</surname><given-names>R</given-names></name><name><surname>Penot</surname><given-names>G</given-names></name><name><surname>Hubner</surname><given-names>MR</given-names></name><name><surname>Reid</surname><given-names>G</given-names></name><name><surname>Brand</surname><given-names>H</given-names></name><name><surname>Kos</surname><given-names>M</given-names></name><name><surname>Gannon</surname><given-names>F</given-names></name></person-group><article-title>Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter</article-title><source>Cell</source><year>2003</year><volume>115</volume><fpage>751</fpage><lpage>763</lpage><pub-id pub-id-type="pmid">14675539</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kouskouti</surname><given-names>A</given-names></name><name><surname>Talianidis</surname><given-names>I</given-names></name></person-group><article-title>Histone modifications defining active genes persist after transcriptional and mitotic inactivation</article-title><source>EMBO J</source><year>2005</year><volume>24</volume><fpage>347</fpage><lpage>357</lpage><pub-id pub-id-type="pmid">15616580</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>An</surname><given-names>W</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Roeder</surname><given-names>RG</given-names></name></person-group><article-title>Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53</article-title><source>Cell</source><year>2004</year><volume>117</volume><fpage>735</fpage><lpage>748</lpage><pub-id pub-id-type="pmid">15186775</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daujat</surname><given-names>S</given-names></name><name><surname>Bauer</surname><given-names>UM</given-names></name><name><surname>Shah</surname><given-names>V</given-names></name><name><surname>Turner</surname><given-names>B</given-names></name><name><surname>Berger</surname><given-names>S</given-names></name><name><surname>Kouzarides</surname><given-names>T</given-names></name></person-group><article-title>Crosstalk between CARM1 methylation and CBP acetylation on histone H3</article-title><source>Curr. Biol</source><year>2002</year><volume>12</volume><fpage>2090</fpage><lpage>2097</lpage><pub-id pub-id-type="pmid">12498683</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agalioti</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>G</given-names></name><name><surname>Thanos</surname><given-names>D</given-names></name></person-group><article-title>Deciphering the transcriptional histone acetylation code for a human gene</article-title><source>Cell</source><year>2002</year><volume>111</volume><fpage>381</fpage><lpage>392</lpage><pub-id pub-id-type="pmid">12419248</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reith</surname><given-names>W</given-names></name><name><surname>Mach</surname><given-names>B</given-names></name></person-group><article-title>The bare lymphocyte syndrome and the regulation of MHC expression</article-title><source>Ann. Rev. Immunol</source><year>2001</year><volume>19</volume><fpage>331</fpage><lpage>373</lpage><pub-id pub-id-type="pmid">11244040</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ting</surname><given-names>JP</given-names></name><name><surname>Trowsdale</surname><given-names>J</given-names></name></person-group><article-title>Genetic control of MHC class II expression</article-title><source>Cell</source><year>2002</year><volume>109</volume><fpage>S21</fpage><lpage>S33</lpage><pub-id pub-id-type="pmid">11983150</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reith</surname><given-names>W</given-names></name><name><surname>LeibundGut-Landmann</surname><given-names>S</given-names></name><name><surname>Waldburger</surname><given-names>JM</given-names></name></person-group><article-title>Regulation of MHC class II gene expression by the class II transactivator</article-title><source>Nat. Rev. Immunol</source><year>2005</year><volume>5</volume><fpage>793</fpage><lpage>806</lpage><pub-id pub-id-type="pmid">16200082</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steimle</surname><given-names>V</given-names></name><name><surname>Otten</surname><given-names>LA</given-names></name><name><surname>Zufferey</surname><given-names>M</given-names></name><name><surname>Mach</surname><given-names>B</given-names></name></person-group><article-title>Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency</article-title><source>Cell</source><year>1993</year><volume>75</volume><fpage>135</fpage><lpage>146</lpage><pub-id pub-id-type="pmid">8402893</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steimle</surname><given-names>V</given-names></name><name><surname>Durand</surname><given-names>B</given-names></name><name><surname>Barras</surname><given-names>E</given-names></name><name><surname>Zufferey</surname><given-names>M</given-names></name><name><surname>Hadam</surname><given-names>MR</given-names></name><name><surname>Mach</surname><given-names>B</given-names></name><name><surname>Reith</surname><given-names>W</given-names></name></person-group><article-title>A novel DNA binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome)</article-title><source>Genes Dev</source><year>1995</year><volume>9</volume><fpage>1021</fpage><lpage>1032</lpage><pub-id pub-id-type="pmid">7744245</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durand</surname><given-names>B</given-names></name><name><surname>Sperisen</surname><given-names>P</given-names></name><name><surname>Emery</surname><given-names>P</given-names></name><name><surname>Barras</surname><given-names>E</given-names></name><name><surname>Zufferey</surname><given-names>M</given-names></name><name><surname>Mach</surname><given-names>B</given-names></name><name><surname>Reith</surname><given-names>W</given-names></name></person-group><article-title>RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency</article-title><source>EMBO J</source><year>1997</year><volume>16</volume><fpage>1045</fpage><lpage>1055</lpage><pub-id pub-id-type="pmid">9118943</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masternak</surname><given-names>K</given-names></name><name><surname>Barras</surname><given-names>E</given-names></name><name><surname>Zufferey</surname><given-names>M</given-names></name><name><surname>Conrad</surname><given-names>B</given-names></name><name><surname>Corthals</surname><given-names>G</given-names></name><name><surname>Aebersold</surname><given-names>R</given-names></name><name><surname>Sanchez</surname><given-names>JC</given-names></name><name><surname>Hochstrasser</surname><given-names>DF</given-names></name><name><surname>Mach</surname><given-names>B</given-names></name><etal/></person-group><article-title>A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients</article-title><source>Nat. Genet</source><year>1998</year><volume>20</volume><fpage>273</fpage><lpage>277</lpage><pub-id pub-id-type="pmid">9806546</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagarajan</surname><given-names>UM</given-names></name><name><surname>Louis-Plence</surname><given-names>P</given-names></name><name><surname>DeSandro</surname><given-names>A</given-names></name><name><surname>Nilsen</surname><given-names>R</given-names></name><name><surname>Bushey</surname><given-names>A</given-names></name><name><surname>Boss</surname><given-names>JM</given-names></name></person-group><article-title>RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency</article-title><source>Immunity</source><year>1999</year><volume>10</volume><fpage>153</fpage><lpage>162</lpage><pub-id pub-id-type="pmid">10072068</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masternak</surname><given-names>K</given-names></name><name><surname>Muhlethaler-Mottet</surname><given-names>A</given-names></name><name><surname>Villard</surname><given-names>J</given-names></name><name><surname>Zufferey</surname><given-names>M</given-names></name><name><surname>Steimle</surname><given-names>V</given-names></name><name><surname>Reith</surname><given-names>W</given-names></name></person-group><article-title>CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex</article-title><source>Genes Dev</source><year>2000</year><volume>14</volume><fpage>1156</fpage><lpage>1166</lpage><pub-id pub-id-type="pmid">10809673</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masternak</surname><given-names>K</given-names></name><name><surname>Peyraud</surname><given-names>N</given-names></name><name><surname>Krawczyk</surname><given-names>M</given-names></name><name><surname>Barras</surname><given-names>E</given-names></name><name><surname>Reith</surname><given-names>W</given-names></name></person-group><article-title>Chromatin remodeling and extragenic transcription at the MHC class II locus control region</article-title><source>Nature Immunol</source><year>2003</year><volume>4</volume><fpage>132</fpage><lpage>137</lpage><pub-id pub-id-type="pmid">12524537</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krawczyk</surname><given-names>M</given-names></name><name><surname>Peyraud</surname><given-names>N</given-names></name><name><surname>Rybtsova</surname><given-names>N</given-names></name><name><surname>Masternak</surname><given-names>K</given-names></name><name><surname>Bucher</surname><given-names>P</given-names></name><name><surname>Barras</surname><given-names>E</given-names></name><name><surname>Reith</surname><given-names>W</given-names></name></person-group><article-title>Long distance control of MHC class II expression by multiple distal enhancers regulated by regulatory factor X complex and CIITA</article-title><source>J. Immunol</source><year>2004</year><volume>173</volume><fpage>6200</fpage><lpage>6210</lpage><pub-id pub-id-type="pmid">15528357</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spilianakis</surname><given-names>C</given-names></name><name><surname>Kretsovali</surname><given-names>A</given-names></name><name><surname>Agalioti</surname><given-names>T</given-names></name><name><surname>Makatounakis</surname><given-names>T</given-names></name><name><surname>Thanos</surname><given-names>D</given-names></name><name><surname>Papamatheakis</surname><given-names>J</given-names></name></person-group><article-title>CIITA regulates transcription onset viaSer5-phosphorylation of RNA Pol II</article-title><source>EMBO J</source><year>2003</year><volume>22</volume><fpage>5125</fpage><lpage>5136</lpage><pub-id pub-id-type="pmid">14517250</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez</surname><given-names>JA</given-names></name><name><surname>Majumder</surname><given-names>P</given-names></name><name><surname>Nagarajan</surname><given-names>UM</given-names></name><name><surname>Boss</surname><given-names>JM</given-names></name></person-group><article-title>X box-like sequences in the MHC class II region maintain regulatory function</article-title><source>J. Immunol</source><year>2005</year><volume>175</volume><fpage>1030</fpage><lpage>1040</lpage><pub-id pub-id-type="pmid">16002703</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beresford</surname><given-names>GW</given-names></name><name><surname>Boss</surname><given-names>JM</given-names></name></person-group><article-title>CIITA coordinates multiple histone acetylation modifications at the HLA- DRA promoter</article-title><source>Nat. Immunol</source><year>2001</year><volume>2</volume><fpage>652</fpage><lpage>657</lpage><pub-id pub-id-type="pmid">11429551</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masternak</surname><given-names>K</given-names></name><name><surname>Reith</surname><given-names>W</given-names></name></person-group><article-title>Promoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activation</article-title><source>EMBO J</source><year>2002</year><volume>21</volume><fpage>1379</fpage><lpage>1388</lpage><pub-id pub-id-type="pmid">11889043</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zika</surname><given-names>E</given-names></name><name><surname>Fauquier</surname><given-names>L</given-names></name><name><surname>Vandel</surname><given-names>L</given-names></name><name><surname>Ting</surname><given-names>JP</given-names></name></person-group><article-title>Interplay among coactivator-associated arginine methyltransferase 1, CBP, and CIITA in IFN-gamma-inducible MHC-II gene expression</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2005</year><volume>102</volume><fpage>16321</fpage><lpage>16326</lpage><pub-id pub-id-type="pmid">16254053</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muhlethaler-Mottet</surname><given-names>A</given-names></name><name><surname>Di Berardino</surname><given-names>W</given-names></name><name><surname>Otten</surname><given-names>LA</given-names></name><name><surname>Mach</surname><given-names>B</given-names></name></person-group><article-title>Activation of the MHC class II transactivator CIITA by interferon-g requires cooperative interaction between Stat1 and USF-1</article-title><source>Immunity</source><year>1998</year><volume>8</volume><fpage>157</fpage><lpage>166</lpage><pub-id pub-id-type="pmid">9491997</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landmann</surname><given-names>S</given-names></name><name><surname>Muhlethaler-Mottet</surname><given-names>A</given-names></name><name><surname>Bernasconi</surname><given-names>L</given-names></name><name><surname>Suter</surname><given-names>T</given-names></name><name><surname>Waldburger</surname><given-names>JM</given-names></name><name><surname>Masternak</surname><given-names>K</given-names></name><name><surname>Arrighi</surname><given-names>JF</given-names></name><name><surname>Hauser</surname><given-names>C</given-names></name><name><surname>Fontana</surname><given-names>A</given-names></name><etal/></person-group><article-title>Maturation of dendritic cells is accompanied by rapid transcriptional silencing of class II transactivator (CIITA) expression</article-title><source>J. Exp. Med</source><year>2001</year><volume>194</volume><fpage>379</fpage><lpage>391</lpage><pub-id pub-id-type="pmid">11514596</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chodosh</surname><given-names>LA</given-names></name><name><surname>Fire</surname><given-names>A</given-names></name><name><surname>Samuels</surname><given-names>M</given-names></name><name><surname>Sharp</surname><given-names>PA</given-names></name></person-group><article-title>5,6-Dichloro-1-beta-D-ribofuranosylbenzimidazole inhibits transcription elongation by RNA polymerase II in vitro</article-title><source>J. Biol. Chem</source><year>1989</year><volume>264</volume><fpage>2250</fpage><lpage>2257</lpage><pub-id pub-id-type="pmid">2914905</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yankulov</surname><given-names>K</given-names></name><name><surname>Yamashita</surname><given-names>K</given-names></name><name><surname>Roy</surname><given-names>R</given-names></name><name><surname>Egly</surname><given-names>JM</given-names></name><name><surname>Bentley</surname><given-names>DL</given-names></name></person-group><article-title>The transcriptional elongation inhibitor 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole inhibits transcription factor IIH-associated protein kinase</article-title><source>J. Biol. Chem</source><year>1995</year><volume>270</volume><fpage>23922</fpage><lpage>23925</lpage><pub-id pub-id-type="pmid">7592583</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanazawa</surname><given-names>S</given-names></name><name><surname>Okamoto</surname><given-names>T</given-names></name><name><surname>Peterlin</surname><given-names>BM</given-names></name></person-group><article-title>Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection</article-title><source>Immunity</source><year>2000</year><volume>12</volume><fpage>61</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">10661406</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kretsovali</surname><given-names>A</given-names></name><name><surname>Agalioti</surname><given-names>T</given-names></name><name><surname>Spilianakis</surname><given-names>C</given-names></name><name><surname>Tzortzakaki</surname><given-names>E</given-names></name><name><surname>Merika</surname><given-names>M</given-names></name><name><surname>Papamatheakis</surname><given-names>J</given-names></name></person-group><article-title>Involvement of CREB binding protein in expression of major histocompatibility complex class II genes via interaction with the class II transactivator</article-title><source>Mol. Cell. Biol</source><year>1998</year><volume>18</volume><fpage>6777</fpage><lpage>6783</lpage><pub-id pub-id-type="pmid">9774691</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontes</surname><given-names>JD</given-names></name><name><surname>Kanazawa</surname><given-names>S</given-names></name><name><surname>Jean</surname><given-names>D</given-names></name><name><surname>Peterlin</surname><given-names>BM</given-names></name></person-group><article-title>Interactions between the class II transactivator and CREB binding protein increase transcription of major histocompatibility complex class II genes</article-title><source>Mol. Cell. Biol</source><year>1999</year><volume>19</volume><fpage>941</fpage><lpage>947</lpage><pub-id pub-id-type="pmid">9858618</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>XS</given-names></name><name><surname>Ting</surname><given-names>JP</given-names></name></person-group><article-title>A 36-amino-acid region of CIITA is an effective inhibitor of CBP: novel mechanism of gamma interferon-mediated suppression of collagen alpha(2)(I) and other promoters</article-title><source>Mol. Cell. Biol</source><year>2001</year><volume>21</volume><fpage>7078</fpage><lpage>7088</lpage><pub-id pub-id-type="pmid">11564890</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spilianakis</surname><given-names>C</given-names></name><name><surname>Papamatheakis</surname><given-names>J</given-names></name><name><surname>Kretsovali</surname><given-names>A</given-names></name></person-group><article-title>Acetylation by PCAF enhances CIITA nuclear accumulation and transactivation of major histocompatibility complex class II genes</article-title><source>Mol. Cell. Biol</source><year>2000</year><volume>20</volume><fpage>8489</fpage><lpage>8498</lpage><pub-id pub-id-type="pmid">11046145</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tzortzakaki</surname><given-names>E</given-names></name><name><surname>Spilianakis</surname><given-names>C</given-names></name><name><surname>Zika</surname><given-names>E</given-names></name><name><surname>Kretsovali</surname><given-names>A</given-names></name><name><surname>Papamatheakis</surname><given-names>J</given-names></name></person-group><article-title>Steroid receptor coactivator 1 links the steroid and interferon gamma response pathways</article-title><source>Mol. Endocrinol</source><year>2003</year><volume>17</volume><fpage>2509</fpage><lpage>2518</lpage><pub-id pub-id-type="pmid">12933903</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raval</surname><given-names>A</given-names></name><name><surname>Howcroft</surname><given-names>TK</given-names></name><name><surname>Weissman</surname><given-names>JD</given-names></name><name><surname>Kirshner</surname><given-names>S</given-names></name><name><surname>Zhu</surname><given-names>XS</given-names></name><name><surname>Yokoyama</surname><given-names>K</given-names></name><name><surname>Ting</surname><given-names>J</given-names></name><name><surname>Singer</surname><given-names>DS</given-names></name></person-group><article-title>Transcriptional coactivator, CIITA, is an acetyltransferase that bypasses a promoter requirement for TAF(II)250</article-title><source>Mol. Cell</source><year>2001</year><volume>7</volume><fpage>105</fpage><lpage>115</lpage><pub-id pub-id-type="pmid">11172716</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plant</surname><given-names>KE</given-names></name><name><surname>Routledge</surname><given-names>SJ</given-names></name><name><surname>Proudfoot</surname><given-names>NJ</given-names></name></person-group><article-title>Intergenic transcription in the human beta-globin gene cluster</article-title><source>Mol. Cell. Biol</source><year>2001</year><volume>21</volume><fpage>6507</fpage><lpage>6514</lpage><pub-id pub-id-type="pmid">11533239</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Routledge</surname><given-names>SJ</given-names></name><name><surname>Proudfoot</surname><given-names>NJ</given-names></name></person-group><article-title>Definition of transcriptional promoters in the human beta globin locus control region</article-title><source>J. Mol. Biol</source><year>2002</year><volume>323</volume><fpage>601</fpage><lpage>611</lpage><pub-id pub-id-type="pmid">12419253</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogan</surname><given-names>DF</given-names></name><name><surname>Cousins</surname><given-names>DJ</given-names></name><name><surname>Santangelo</surname><given-names>S</given-names></name><name><surname>Ioannou</surname><given-names>PA</given-names></name><name><surname>Antoniou</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>TH</given-names></name><name><surname>Staynov</surname><given-names>DZ</given-names></name></person-group><article-title>Analysis of intergenic transcription in the human IL-4/IL-13 gene cluster</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2004</year><volume>101</volume><fpage>2446</fpage><lpage>2451</lpage><pub-id pub-id-type="pmid">14983029</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolland</surname><given-names>DJ</given-names></name><name><surname>Wood</surname><given-names>AL</given-names></name><name><surname>Johnston</surname><given-names>CM</given-names></name><name><surname>Bunting</surname><given-names>SF</given-names></name><name><surname>Morgan</surname><given-names>G</given-names></name><name><surname>Chakalova</surname><given-names>L</given-names></name><name><surname>Fraser</surname><given-names>PJ</given-names></name><name><surname>Corcoran</surname><given-names>AE</given-names></name></person-group><article-title>Antisense intergenic transcription in V(D)J recombination</article-title><source>Nat. Immunol</source><year>2004</year><volume>5</volume><fpage>630</fpage><lpage>637</lpage><pub-id pub-id-type="pmid">15107847</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmitt</surname><given-names>S</given-names></name><name><surname>Prestel</surname><given-names>M</given-names></name><name><surname>Paro</surname><given-names>R</given-names></name></person-group><article-title>Intergenic transcription through a polycomb group response element counteracts silencing</article-title><source>Genes Dev</source><year>2005</year><volume>19</volume><fpage>697</fpage><lpage>708</lpage><pub-id pub-id-type="pmid">15741315</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gribnau</surname><given-names>J</given-names></name><name><surname>Diderich</surname><given-names>K</given-names></name><name><surname>Pruzina</surname><given-names>S</given-names></name><name><surname>Calzolari</surname><given-names>R</given-names></name><name><surname>Fraser</surname><given-names>P</given-names></name></person-group><article-title>Intergenic transcription and developmental remodeling of chromatin subdomains in the human beta-globin locus</article-title><source>Mol. Cell</source><year>2000</year><volume>5</volume><fpage>377</fpage><lpage>386</lpage><pub-id pub-id-type="pmid">10882078</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engel</surname><given-names>JD</given-names></name><name><surname>Tanimoto</surname><given-names>K</given-names></name></person-group><article-title>Looping, linking, and chromatin activity: new insights into beta-globin locus regulation</article-title><source>Cell</source><year>2000</year><volume>100</volume><fpage>499</fpage><lpage>502</lpage><pub-id pub-id-type="pmid">10721987</pub-id></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Svejstrup</surname><given-names>JQ</given-names></name></person-group><article-title>The RNA polymerase II transcription cycle: cycling through chromatin</article-title><source>Biochim. Biophys. Acta</source><year>2004</year><volume>1677</volume><fpage>64</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">15020047</pub-id></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wittschieben</surname><given-names>BO</given-names></name><name><surname>Otero</surname><given-names>G</given-names></name><name><surname>de Bizemont</surname><given-names>T</given-names></name><name><surname>Fellows</surname><given-names>J</given-names></name><name><surname>Erdjument-Bromage</surname><given-names>H</given-names></name><name><surname>Ohba</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Allis</surname><given-names>CD</given-names></name><name><surname>Tempst</surname><given-names>P</given-names></name><etal/></person-group><article-title>A novel histone acetyltransferase is an integral subunit of elongating RNA polymerase II holoenzyme</article-title><source>Mol. Cell</source><year>1999</year><volume>4</volume><fpage>123</fpage><lpage>128</lpage><pub-id pub-id-type="pmid">10445034</pub-id></element-citation></ref><ref id="B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hawkes</surname><given-names>NA</given-names></name><name><surname>Otero</surname><given-names>G</given-names></name><name><surname>Winkler</surname><given-names>GS</given-names></name><name><surname>Marshall</surname><given-names>N</given-names></name><name><surname>Dahmus</surname><given-names>ME</given-names></name><name><surname>Krappmann</surname><given-names>D</given-names></name><name><surname>Scheidereit</surname><given-names>C</given-names></name><name><surname>Thomas</surname><given-names>CL</given-names></name><name><surname>Schiavo</surname><given-names>G</given-names></name><etal/></person-group><article-title>Purification and characterization of the human elongator complex</article-title><source>J. Biol. Chem</source><year>2002</year><volume>277</volume><fpage>3047</fpage><lpage>3052</lpage><pub-id pub-id-type="pmid">11714725</pub-id></element-citation></ref><ref id="B54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Lane</surname><given-names>WS</given-names></name><name><surname>Reinberg</surname><given-names>D</given-names></name></person-group><article-title>Human elongator facilitates RNA polymerase II transcription through chromatin</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2002</year><volume>99</volume><fpage>1241</fpage><lpage>1246</lpage><pub-id pub-id-type="pmid">11818576</pub-id></element-citation></ref><ref id="B55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Travers</surname><given-names>A</given-names></name></person-group><article-title>Chromatin modification by DNA tracking</article-title><source>Proc. Natl Acad. Sci. USA</source><year>1999</year><volume>96</volume><fpage>13634</fpage><lpage>13637</lpage><pub-id pub-id-type="pmid">10570124</pub-id></element-citation></ref><ref id="B56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carson</surname><given-names>S</given-names></name><name><surname>Wiles</surname><given-names>MV</given-names></name></person-group><article-title>Far upstream regions of class II MHC Ea are necessary for position-independent, copy-dependent expression of Ea transgene</article-title><source>Nucleic Acids Res</source><year>1993</year><volume>21</volume><fpage>2065</fpage><lpage>2072</lpage><pub-id pub-id-type="pmid">8502547</pub-id></element-citation></ref><ref id="B57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carson</surname><given-names>S</given-names></name></person-group><article-title>DNase I hypersensitive sites flank the mouse class II major histocompatibility complex during B cell development</article-title><source>Nucleic Acids Res</source><year>1991</year><volume>19</volume><fpage>5007</fpage><lpage>5014</lpage><pub-id pub-id-type="pmid">1923768</pub-id></element-citation></ref><ref id="B58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorn</surname><given-names>A</given-names></name><name><surname>Fehling</surname><given-names>HJ</given-names></name><name><surname>Koch</surname><given-names>W</given-names></name><name><surname>Lemeur</surname><given-names>M</given-names></name><name><surname>Gerlinger</surname><given-names>P</given-names></name><name><surname>Benoist</surname><given-names>C</given-names></name><name><surname>Mathis</surname><given-names>D</given-names></name></person-group><article-title>B cell control region at the 5&#x02032; end of a major histocompatibility complex class II gene: sequences and factors</article-title><source>Mol. Cell. Biol</source><year>1988</year><volume>8</volume><fpage>3975</fpage><lpage>3987</lpage><pub-id pub-id-type="pmid">3141781</pub-id></element-citation></ref><ref id="B59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pokholok</surname><given-names>DK</given-names></name><name><surname>Harbison</surname><given-names>CT</given-names></name><name><surname>Levine</surname><given-names>S</given-names></name><name><surname>Cole</surname><given-names>M</given-names></name><name><surname>Hannett</surname><given-names>NM</given-names></name><name><surname>Lee</surname><given-names>TI</given-names></name><name><surname>Bell</surname><given-names>GW</given-names></name><name><surname>Walker</surname><given-names>K</given-names></name><name><surname>Rolfe</surname><given-names>PA</given-names></name><etal/></person-group><article-title>Genome-wide map of nucleosome acetylation and methylation in yeast</article-title><source>Cell</source><year>2005</year><volume>122</volume><fpage>517</fpage><lpage>527</lpage><pub-id pub-id-type="pmid">16122420</pub-id></element-citation></ref><ref id="B60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>CL</given-names></name><name><surname>Kaplan</surname><given-names>T</given-names></name><name><surname>Kim</surname><given-names>M</given-names></name><name><surname>Buratowski</surname><given-names>S</given-names></name><name><surname>Schreiber</surname><given-names>SL</given-names></name><name><surname>Friedman</surname><given-names>N</given-names></name><name><surname>Rando</surname><given-names>OJ</given-names></name></person-group><article-title>Single-nucleosome mapping of histone modifications in S. cerevisiae</article-title><source>PLoS Biol</source><year>2005</year><volume>3</volume><fpage>e328</fpage><pub-id pub-id-type="pmid">16122352</pub-id></element-citation></ref><ref id="B61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sedkov</surname><given-names>Y</given-names></name><name><surname>Cho</surname><given-names>E</given-names></name><name><surname>Petruk</surname><given-names>S</given-names></name><name><surname>Cherbas</surname><given-names>L</given-names></name><name><surname>Smith</surname><given-names>ST</given-names></name><name><surname>Jones</surname><given-names>RS</given-names></name><name><surname>Cherbas</surname><given-names>P</given-names></name><name><surname>Canaani</surname><given-names>E</given-names></name><name><surname>Jaynes</surname><given-names>JB</given-names></name><etal/></person-group><article-title>Methylation at lysine 4 of histone H3 in ecdysone-dependent development of Drosophila</article-title><source>Nature</source><year>2003</year><volume>426</volume><fpage>78</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">14603321</pub-id></element-citation></ref><ref id="B62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milne</surname><given-names>TA</given-names></name><name><surname>Briggs</surname><given-names>SD</given-names></name><name><surname>Brock</surname><given-names>HW</given-names></name><name><surname>Martin</surname><given-names>ME</given-names></name><name><surname>Gibbs</surname><given-names>D</given-names></name><name><surname>Allis</surname><given-names>CD</given-names></name><name><surname>Hess</surname><given-names>JL</given-names></name></person-group><article-title>MLL targets SET domain methyltransferase activity to Hox gene promoters</article-title><source>Mol. Cell</source><year>2002</year><volume>10</volume><fpage>1107</fpage><lpage>1117</lpage><pub-id pub-id-type="pmid">12453418</pub-id></element-citation></ref><ref id="B63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Mori</surname><given-names>T</given-names></name><name><surname>Tada</surname><given-names>S</given-names></name><name><surname>Krajewski</surname><given-names>W</given-names></name><name><surname>Rozovskaia</surname><given-names>T</given-names></name><name><surname>Wassell</surname><given-names>R</given-names></name><name><surname>Dubois</surname><given-names>G</given-names></name><name><surname>Mazo</surname><given-names>A</given-names></name><name><surname>Croce</surname><given-names>CM</given-names></name><etal/></person-group><article-title>ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation</article-title><source>Mol. Cell</source><year>2002</year><volume>10</volume><fpage>1119</fpage><lpage>1128</lpage><pub-id pub-id-type="pmid">12453419</pub-id></element-citation></ref><ref id="B64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wysocka</surname><given-names>J</given-names></name><name><surname>Myers</surname><given-names>MP</given-names></name><name><surname>Laherty</surname><given-names>CD</given-names></name><name><surname>Eisenman</surname><given-names>RN</given-names></name><name><surname>Herr</surname><given-names>W</given-names></name></person-group><article-title>Human Sin3 deacetylase and trithorax-related Set1/Ash2 histone H3-K4 methyltransferase are tethered together selectively by the cell-proliferation factor HCF-1</article-title><source>Genes Dev</source><year>2003</year><volume>17</volume><fpage>896</fpage><lpage>911</lpage><pub-id pub-id-type="pmid">12670868</pub-id></element-citation></ref><ref id="B65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dou</surname><given-names>Y</given-names></name><name><surname>Milne</surname><given-names>TA</given-names></name><name><surname>Tackett</surname><given-names>AJ</given-names></name><name><surname>Smith</surname><given-names>ER</given-names></name><name><surname>Fukuda</surname><given-names>A</given-names></name><name><surname>Wysocka</surname><given-names>J</given-names></name><name><surname>Allis</surname><given-names>CD</given-names></name><name><surname>Chait</surname><given-names>BT</given-names></name><name><surname>Hess</surname><given-names>JL</given-names></name><etal/></person-group><article-title>Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyltransferase MOF</article-title><source>Cell</source><year>2005</year><volume>121</volume><fpage>873</fpage><lpage>885</lpage><pub-id pub-id-type="pmid">15960975</pub-id></element-citation></ref><ref id="B66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miao</surname><given-names>F</given-names></name><name><surname>Natarajan</surname><given-names>R</given-names></name></person-group><article-title>Mapping global histone methylation patterns in the coding regions of human genes</article-title><source>Mol. Cell. Biol</source><year>2005</year><volume>25</volume><fpage>4650</fpage><lpage>4661</lpage><pub-id pub-id-type="pmid">15899867</pub-id></element-citation></ref><ref id="B67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schubeler</surname><given-names>D</given-names></name><name><surname>MacAlpine</surname><given-names>DM</given-names></name><name><surname>Scalzo</surname><given-names>D</given-names></name><name><surname>Wirbelauer</surname><given-names>C</given-names></name><name><surname>Kooperberg</surname><given-names>C</given-names></name><name><surname>van</surname><given-names>LF</given-names></name><name><surname>Gottschling</surname><given-names>DE</given-names></name><name><surname>O'Neill</surname><given-names>LP</given-names></name><name><surname>Turner</surname><given-names>BM</given-names></name><etal/></person-group><article-title>The histone modification pattern of active genes revealed through genome-wide chromatin analysis of a higher eukaryote</article-title><source>Genes Dev</source><year>2004</year><volume>18</volume><fpage>1263</fpage><lpage>1271</lpage><pub-id pub-id-type="pmid">15175259</pub-id></element-citation></ref><ref id="B68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>G</given-names></name><name><surname>Lin</surname><given-names>JC</given-names></name><name><surname>Wei</surname><given-names>V</given-names></name><name><surname>Yoo</surname><given-names>C</given-names></name><name><surname>Cheng</surname><given-names>JC</given-names></name><name><surname>Nguyen</surname><given-names>CT</given-names></name><name><surname>Weisenberger</surname><given-names>DJ</given-names></name><name><surname>Egger</surname><given-names>G</given-names></name><name><surname>Takai</surname><given-names>D</given-names></name><etal/></person-group><article-title>Distinct localization of histone H3 acetylation and H3-K4 methylation to the transcription start sites in the human genome</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2004</year><volume>101</volume><fpage>7357</fpage><lpage>7362</lpage><pub-id pub-id-type="pmid">15123803</pub-id></element-citation></ref><ref id="B69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>R</given-names></name><name><surname>Bannister</surname><given-names>AJ</given-names></name><name><surname>Myers</surname><given-names>FA</given-names></name><name><surname>Thorne</surname><given-names>AW</given-names></name><name><surname>Crane-Robinson</surname><given-names>C</given-names></name><name><surname>Kouzarides</surname><given-names>T</given-names></name></person-group><article-title>Histone H3 lysine 4 methylation patterns in higher eukaryotic genes</article-title><source>Nat. Cell Biol</source><year>2004</year><volume>6</volume><fpage>73</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">14661024</pub-id></element-citation></ref><ref id="B70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernstein</surname><given-names>BE</given-names></name><name><surname>Kamal</surname><given-names>M</given-names></name><name><surname>Lindblad-Toh</surname><given-names>K</given-names></name><name><surname>Bekiranov</surname><given-names>S</given-names></name><name><surname>Bailey</surname><given-names>DK</given-names></name><name><surname>Huebert</surname><given-names>DJ</given-names></name><name><surname>McMahon</surname><given-names>S</given-names></name><name><surname>Karlsson</surname><given-names>EK</given-names></name><name><surname>Kulbokas</surname><given-names>EJ</given-names><suffix>III</suffix></name><etal/></person-group><article-title>Genomic maps and comparative analysis of histone modifications in human and mouse</article-title><source>Cell</source><year>2005</year><volume>120</volume><fpage>169</fpage><lpage>181</lpage><pub-id pub-id-type="pmid">15680324</pub-id></element-citation></ref><ref id="B71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pavri</surname><given-names>R</given-names></name><name><surname>Zhu</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Trojer</surname><given-names>P</given-names></name><name><surname>Mandal</surname><given-names>S</given-names></name><name><surname>Shilatifard</surname><given-names>A</given-names></name><name><surname>Reinberg</surname><given-names>D</given-names></name></person-group><article-title>Histone H2B monoubiquitination functions cooperatively with FACT to regulate elongation by RNA polymerase II</article-title><source>Cell</source><year>2006</year><volume>125</volume><fpage>703</fpage><lpage>717</lpage><pub-id pub-id-type="pmid">16713563</pub-id></element-citation></ref><ref id="B72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinha</surname><given-names>I</given-names></name><name><surname>Wiren</surname><given-names>M</given-names></name><name><surname>Ekwall</surname><given-names>K</given-names></name></person-group><article-title>Genome-wide patterns of histone modifications in fission yeast</article-title><source>Chromosome Res</source><year>2006</year><volume>14</volume><fpage>95</fpage><lpage>105</lpage><pub-id pub-id-type="pmid">16506099</pub-id></element-citation></ref><ref id="B73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roh</surname><given-names>TY</given-names></name><name><surname>Cuddapah</surname><given-names>S</given-names></name><name><surname>Zhao</surname><given-names>K</given-names></name></person-group><article-title>Active chromatin domains are defined by acetylation islands revealed by genome-wide mapping</article-title><source>Genes Dev</source><year>2005</year><volume>19</volume><fpage>542</fpage><lpage>552</lpage><pub-id pub-id-type="pmid">15706033</pub-id></element-citation></ref><ref id="B74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hazzalin</surname><given-names>CA</given-names></name><name><surname>Mahadevan</surname><given-names>LC</given-names></name></person-group><article-title>Dynamic acetylation of all lysine 4-methylated histone H3 in the mouse nucleus: analysis at c-fos and c-jun</article-title><source>PLoS Biol</source><year>2005</year><volume>3</volume><fpage>e393</fpage><pub-id pub-id-type="pmid">16262446</pub-id></element-citation></ref><ref id="B75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pray-Grant</surname><given-names>MG</given-names></name><name><surname>Daniel</surname><given-names>JA</given-names></name><name><surname>Schieltz</surname><given-names>D</given-names></name><name><surname>Yates</surname><given-names>JR</given-names><suffix>III</suffix></name><name><surname>Grant</surname><given-names>PA</given-names></name></person-group><article-title>Chd1 chromodomain links histone H3 methylation with</article-title><source>Nature</source><year>2005</year><volume>433</volume><fpage>434</fpage><lpage>438</lpage><pub-id pub-id-type="pmid">15647753</pub-id></element-citation></ref><ref id="B76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Covic</surname><given-names>M</given-names></name><name><surname>Hassa</surname><given-names>PO</given-names></name><name><surname>Saccani</surname><given-names>S</given-names></name><name><surname>Buerki</surname><given-names>C</given-names></name><name><surname>Meier</surname><given-names>NI</given-names></name><name><surname>Lombardi</surname><given-names>C</given-names></name><name><surname>Imhof</surname><given-names>R</given-names></name><name><surname>Bedford</surname><given-names>MT</given-names></name><name><surname>Natoli</surname><given-names>G</given-names></name><etal/></person-group><article-title>Arginine methyltransferase CARM1 is a promoter-specific regulator of NF-kappaB-dependent gene expression</article-title><source>EMBO J</source><year>2005</year><volume>24</volume><fpage>85</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">15616592</pub-id></element-citation></ref></ref-list></back></article>
